$GNLX
Genelux Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$2.52
▼-0.79%-$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateGenelux Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is GNLX down today? It is at $2.52 (-0.79%), and our scanner flagged it 15 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GNLX spikes, and full due diligence on GNLX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $GNLX 15 times in the last 30 days. Create a free account to track $GNLX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on GNLX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GNLX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Cappello Joseph Officer | Sold (automatic/other) | -10K 0.02% of company | sold 3.1% | 318K | $28K at $2.74 | Aug 31, 26 |
Zindrick Thomas Officer | Sold (automatic/other) | -34K 0.08% of company | sold 2.7% | 1.23M | $92K at $2.67 | Aug 31, 26 |
Yu Yong Officer | Sold (automatic/other) | -10K 0.02% of company | sold 3.6% | 259K | $27K at $2.75 | Aug 31, 26 |
Yu Yong Officer | Sold (automatic/other) | -653 | sold 0.2% | 268K | $2K at $2.94 | Aug 4, 26 |
Zindrick Thomas Officer | Sold (automatic/other) | -3K | sold 0.2% | 1.26M | $9K at $2.95 | Aug 4, 26 |
Cappello Joseph Officer | Sold (automatic/other) | -653 | sold 0.2% | 329K | $2K at $2.95 | Aug 4, 26 |
Smither John W Director | Sold (automatic/other) | -12K 0.03% of company | sold 12% | 91K | $35K at $2.91 | Jul 1, 26 |
Yu Yong Officer | Acquired (grant/award) | +119K 0.3% of company | added 80% | 269K | n/a | Jun 16, 26 |
Smither John W Director | Acquired (grant/award) | +28K 0.06% of company | added 38% | 103K | n/a | Jun 16, 26 |
Cappello Joseph Officer | Acquired (grant/award) | +175K 0.4% of company | added 100% | 329K | n/a | Jun 16, 26 |
Mirabelli Mary Director | Acquired (grant/award) | +28K 0.06% of company | added 38% | 103K | n/a | Jun 16, 26 |
Pulisic Matthew Officer | Acquired (grant/award) | +279K 0.6% of company | n/a | 279K | n/a | Jun 16, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on GNLX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GNLX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
GNLX last traded at $2.52, down 0.79% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Genelux Corporation Common Stock (GNLX) is next expected to report earnings on Wednesday, November 4, 2026, about 28 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The GNLX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GNLX 15 times in the last 30 days.
GNLX (Genelux Corporation Common Stock) trades on XNAS, with a market cap of about $114M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GNLX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$GNLX discussion
Sign in to ask a question or join the discussion.